StonvexLoading…
StonvexStonvexStonvexCore line items from JRSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $145.81M | $117.19M | $138.06M | $143.35M |
Operating Income | $1.45M | $-664.96K | $4.41M | $10.49M |
Net Income | $-848.37K | $-2.01M | $2.42M | $7.92M |
EPS (Diluted) | $-0.07 | $-0.16 | $0.19 | $0.67 |
Total Assets | $82.98M | $80.25M | $83.72M | $85.31M |
Total Liabilities | $20.11M | $15.81M | $15.49M | $16.01M |
Cash & Equivalents | $13.35M | $12.43M | $17.80M | $25.18M |
Free Cash Flow OCF − CapEx | $413.52K | $1.24M | $10.08M | $6.01M |
Shares Outstanding | 12.70M | 12.29M | 12.29M | 12.33M |